Allianz Asset Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,400
| Closed | -$604K | – | 1748 |
|
|
2024
Q3 | $604K | Buy |
10,400
+1,500
| +17% | +$87.1K | ﹤0.01% | 1375 |
|
|
2024
Q2 | $407K | Hold |
8,900
| – | – | ﹤0.01% | 1467 |
|
|
2024
Q1 | $589K | Buy |
+8,900
| New | +$589K | ﹤0.01% | 1376 |
|
|
2023
Q4 | – | Sell |
-12,200
| Closed | -$389K | – | 1666 |
|
|
2023
Q3 | $389K | Hold |
12,200
| – | – | ﹤0.01% | 1516 |
|
|
2023
Q2 | $490K | Hold |
12,200
| – | – | ﹤0.01% | 1317 |
|
|
2023
Q1 | $521K | Sell |
12,200
-4,000
| -25% | -$171K | ﹤0.01% | 1425 |
|
|
2022
Q4 | $778K | Sell |
16,200
-2,000
| -11% | -$96K | ﹤0.01% | 1271 |
|
|
2022
Q3 | $685K | Sell |
18,200
-110,077
| -86% | -$4.14M | ﹤0.01% | 1269 |
|
|
2022
Q2 | $3.54M | Buy |
128,277
+52,886
| +70% | +$1.46M | ﹤0.01% | 1139 |
|
|
2022
Q1 | $4.1M | Buy |
75,391
+27,544
| +58% | +$1.5M | ﹤0.01% | 1147 |
|
|
2021
Q4 | $2.79M | Buy |
+47,847
| New | +$2.79M | ﹤0.01% | 1305 |
|